Search

everythinglearnresearchcommunity

for

Search:↓

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Androgens increase norepinephrine release, promoting smooth muscle growth in male sex organs, which may contribute to benign prostatic hypertrophy.

DPP may help hair regrowth by improving blood vessel function under stress.

Combining PRP with minoxidil improves hair growth and satisfaction more than minoxidil alone.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

5α-reduced progestogens may reduce mood issues and brain damage linked to HIV-1 Tat.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Targeting FGFR-1 with antisense oligonucleotides may help treat baldness by increasing hair follicle activity.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

Carvacrol activates the TRPV3 channel, which may help design new skin treatments.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

GABAergic steroid precursors reduce ethanol withdrawal symptoms in certain mice.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

PRP injections may be an effective treatment for severe hair loss.

Stopping alcohol after long-term use causes anxiety and changes brain chemicals.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

Activating TRPV1 can boost hair growth by involving neurons, macrophages, and fibroblasts.